The global Natural Killer Cell Therapeutics market size was estimated at USD 135 million in 2024 and is projected to reach USD 2631.95 million by 2032, exhibiting a CAGR of 39.10% during the forecast period.
North America Natural Killer Cell Therapeutics market size was estimated at USD 62.71 million in 2024, at a CAGR of 33.51% during the forecast period of 2025 through 2032.
Report Overview
NK cells, a type of immune cell, have received a lot of attention for their natural capacity to recognize and kill malignant cells. Advances in understanding NK cell biology and its interactions with Cancer have resulted in the development of new medicines that harness the potential of these cells. With the success of CAR-NK cell therapies in preclinical and early clinical trials, there is growing optimism about the ability of NK cell-based immunotherapies to treat a wide spectrum of cancer types.
This report provides a deep insight into the global Natural Killer Cell Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Natural Killer Cell Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Natural Killer Cell Therapeutics market in any manner.
Global Natural Killer Cell Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Merck KGaA
- Bristol-Myers Squibb Company
- Glycostem
- Sanofi
- Cytovia Therapeutics
- ImmunityBio
- Inc.
- Biohaven Pharmaceuticals
- Fate Therapeutics
- EMERcell
- Phio Pharmaceuticals
Market Segmentation (by Type)
- NK Cell Therapies
- NK Cell Directed Antibodies
Market Segmentation (by Application)
- Research & Academic Institutes
- Hospitals
- Specialty Clinics
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Natural Killer Cell Therapeutics Market
- Overview of the regional outlook of the Natural Killer Cell Therapeutics Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Natural Killer Cell Therapeutics
1.2 Key Market Segments
1.2.1 Natural Killer Cell Therapeutics Segment by Type
1.2.2 Natural Killer Cell Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Natural Killer Cell Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Natural Killer Cell Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Natural Killer Cell Therapeutics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Natural Killer Cell Therapeutics Market Competitive Landscape
3.1 Global Natural Killer Cell Therapeutics Sales by Manufacturers (2019-2025)
3.2 Global Natural Killer Cell Therapeutics Revenue Market Share by Manufacturers (2019-2025)
3.3 Natural Killer Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Natural Killer Cell Therapeutics Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Natural Killer Cell Therapeutics Sales Sites, Area Served, Product Type
3.6 Natural Killer Cell Therapeutics Market Competitive Situation and Trends
3.6.1 Natural Killer Cell Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Natural Killer Cell Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Natural Killer Cell Therapeutics Industry Chain Analysis
4.1 Natural Killer Cell Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Natural Killer Cell Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Natural Killer Cell Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Natural Killer Cell Therapeutics Sales Market Share by Type (2019-2025)
6.3 Global Natural Killer Cell Therapeutics Market Size Market Share by Type (2019-2025)
6.4 Global Natural Killer Cell Therapeutics Price by Type (2019-2025)
7 Natural Killer Cell Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Natural Killer Cell Therapeutics Market Sales by Application (2019-2025)
7.3 Global Natural Killer Cell Therapeutics Market Size (M USD) by Application (2019-2025)
7.4 Global Natural Killer Cell Therapeutics Sales Growth Rate by Application (2019-2025)
8 Natural Killer Cell Therapeutics Market Consumption by Region
8.1 Global Natural Killer Cell Therapeutics Sales by Region
8.1.1 Global Natural Killer Cell Therapeutics Sales by Region
8.1.2 Global Natural Killer Cell Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Natural Killer Cell Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Natural Killer Cell Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Natural Killer Cell Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Natural Killer Cell Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Natural Killer Cell Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Natural Killer Cell Therapeutics Market Production by Region
9.1 Global Production of Natural Killer Cell Therapeutics by Region (2019-2025)
9.2 Global Natural Killer Cell Therapeutics Revenue Market Share by Region (2019-2025)
9.3 Global Natural Killer Cell Therapeutics Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Natural Killer Cell Therapeutics Production
9.4.1 North America Natural Killer Cell Therapeutics Production Growth Rate (2019-2025)
9.4.2 North America Natural Killer Cell Therapeutics Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Natural Killer Cell Therapeutics Production
9.5.1 Europe Natural Killer Cell Therapeutics Production Growth Rate (2019-2025)
9.5.2 Europe Natural Killer Cell Therapeutics Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Natural Killer Cell Therapeutics Production (2019-2025)
9.6.1 Japan Natural Killer Cell Therapeutics Production Growth Rate (2019-2025)
9.6.2 Japan Natural Killer Cell Therapeutics Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Natural Killer Cell Therapeutics Production (2019-2025)
9.7.1 China Natural Killer Cell Therapeutics Production Growth Rate (2019-2025)
9.7.2 China Natural Killer Cell Therapeutics Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Merck KGaA
10.1.1 Merck KGaA Natural Killer Cell Therapeutics Basic Information
10.1.2 Merck KGaA Natural Killer Cell Therapeutics Product Overview
10.1.3 Merck KGaA Natural Killer Cell Therapeutics Product Market Performance
10.1.4 Merck KGaA Business Overview
10.1.5 Merck KGaA Natural Killer Cell Therapeutics SWOT Analysis
10.1.6 Merck KGaA Recent Developments
10.2 Bristol-Myers Squibb Company
10.2.1 Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Basic Information
10.2.2 Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Product Overview
10.2.3 Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Product Market Performance
10.2.4 Bristol-Myers Squibb Company Business Overview
10.2.5 Bristol-Myers Squibb Company Natural Killer Cell Therapeutics SWOT Analysis
10.2.6 Bristol-Myers Squibb Company Recent Developments
10.3 Glycostem
10.3.1 Glycostem Natural Killer Cell Therapeutics Basic Information
10.3.2 Glycostem Natural Killer Cell Therapeutics Product Overview
10.3.3 Glycostem Natural Killer Cell Therapeutics Product Market Performance
10.3.4 Glycostem Natural Killer Cell Therapeutics SWOT Analysis
10.3.5 Glycostem Business Overview
10.3.6 Glycostem Recent Developments
10.4 Sanofi
10.4.1 Sanofi Natural Killer Cell Therapeutics Basic Information
10.4.2 Sanofi Natural Killer Cell Therapeutics Product Overview
10.4.3 Sanofi Natural Killer Cell Therapeutics Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 Cytovia Therapeutics
10.5.1 Cytovia Therapeutics Natural Killer Cell Therapeutics Basic Information
10.5.2 Cytovia Therapeutics Natural Killer Cell Therapeutics Product Overview
10.5.3 Cytovia Therapeutics Natural Killer Cell Therapeutics Product Market Performance
10.5.4 Cytovia Therapeutics Business Overview
10.5.5 Cytovia Therapeutics Recent Developments
10.6 ImmunityBio
10.6.1 ImmunityBio Natural Killer Cell Therapeutics Basic Information
10.6.2 ImmunityBio Natural Killer Cell Therapeutics Product Overview
10.6.3 ImmunityBio Natural Killer Cell Therapeutics Product Market Performance
10.6.4 ImmunityBio Business Overview
10.6.5 ImmunityBio Recent Developments
10.7 Inc.
10.7.1 Inc. Natural Killer Cell Therapeutics Basic Information
10.7.2 Inc. Natural Killer Cell Therapeutics Product Overview
10.7.3 Inc. Natural Killer Cell Therapeutics Product Market Performance
10.7.4 Inc. Business Overview
10.7.5 Inc. Recent Developments
10.8 Biohaven Pharmaceuticals
10.8.1 Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Basic Information
10.8.2 Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Product Overview
10.8.3 Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Product Market Performance
10.8.4 Biohaven Pharmaceuticals Business Overview
10.8.5 Biohaven Pharmaceuticals Recent Developments
10.9 Fate Therapeutics
10.9.1 Fate Therapeutics Natural Killer Cell Therapeutics Basic Information
10.9.2 Fate Therapeutics Natural Killer Cell Therapeutics Product Overview
10.9.3 Fate Therapeutics Natural Killer Cell Therapeutics Product Market Performance
10.9.4 Fate Therapeutics Business Overview
10.9.5 Fate Therapeutics Recent Developments
10.10 EMERcell
10.10.1 EMERcell Natural Killer Cell Therapeutics Basic Information
10.10.2 EMERcell Natural Killer Cell Therapeutics Product Overview
10.10.3 EMERcell Natural Killer Cell Therapeutics Product Market Performance
10.10.4 EMERcell Business Overview
10.10.5 EMERcell Recent Developments
10.11 Phio Pharmaceuticals
10.11.1 Phio Pharmaceuticals Natural Killer Cell Therapeutics Basic Information
10.11.2 Phio Pharmaceuticals Natural Killer Cell Therapeutics Product Overview
10.11.3 Phio Pharmaceuticals Natural Killer Cell Therapeutics Product Market Performance
10.11.4 Phio Pharmaceuticals Business Overview
10.11.5 Phio Pharmaceuticals Recent Developments
11 Natural Killer Cell Therapeutics Market Forecast by Region
11.1 Global Natural Killer Cell Therapeutics Market Size Forecast
11.2 Global Natural Killer Cell Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Natural Killer Cell Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Natural Killer Cell Therapeutics Market Size Forecast by Region
11.2.4 South America Natural Killer Cell Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Natural Killer Cell Therapeutics by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Natural Killer Cell Therapeutics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Natural Killer Cell Therapeutics by Type (2025-2032)
12.1.2 Global Natural Killer Cell Therapeutics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Natural Killer Cell Therapeutics by Type (2025-2032)
12.2 Global Natural Killer Cell Therapeutics Market Forecast by Application (2025-2032)
12.2.1 Global Natural Killer Cell Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Natural Killer Cell Therapeutics Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Natural Killer Cell Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Natural Killer Cell Therapeutics Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Natural Killer Cell Therapeutics Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Natural Killer Cell Therapeutics Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Natural Killer Cell Therapeutics Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapeutics as of 2022)
Table 10. Global Market Natural Killer Cell Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Natural Killer Cell Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Natural Killer Cell Therapeutics Product Type
Table 13. Global Natural Killer Cell Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Natural Killer Cell Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Natural Killer Cell Therapeutics Market Challenges
Table 22. Global Natural Killer Cell Therapeutics Sales by Type (K Units)
Table 23. Global Natural Killer Cell Therapeutics Market Size by Type (M USD)
Table 24. Global Natural Killer Cell Therapeutics Sales (K Units) by Type (2019-2025)
Table 25. Global Natural Killer Cell Therapeutics Sales Market Share by Type (2019-2025)
Table 26. Global Natural Killer Cell Therapeutics Market Size (M USD) by Type (2019-2025)
Table 27. Global Natural Killer Cell Therapeutics Market Size Share by Type (2019-2025)
Table 28. Global Natural Killer Cell Therapeutics Price (USD/Unit) by Type (2019-2025)
Table 29. Global Natural Killer Cell Therapeutics Sales (K Units) by Application
Table 30. Global Natural Killer Cell Therapeutics Market Size by Application
Table 31. Global Natural Killer Cell Therapeutics Sales by Application (2019-2025) & (K Units)
Table 32. Global Natural Killer Cell Therapeutics Sales Market Share by Application (2019-2025)
Table 33. Global Natural Killer Cell Therapeutics Sales by Application (2019-2025) & (M USD)
Table 34. Global Natural Killer Cell Therapeutics Market Share by Application (2019-2025)
Table 35. Global Natural Killer Cell Therapeutics Sales Growth Rate by Application (2019-2025)
Table 36. Global Natural Killer Cell Therapeutics Sales by Region (2019-2025) & (K Units)
Table 37. Global Natural Killer Cell Therapeutics Sales Market Share by Region (2019-2025)
Table 38. North America Natural Killer Cell Therapeutics Sales by Country (2019-2025) & (K Units)
Table 39. Europe Natural Killer Cell Therapeutics Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Natural Killer Cell Therapeutics Sales by Region (2019-2025) & (K Units)
Table 41. South America Natural Killer Cell Therapeutics Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Natural Killer Cell Therapeutics Sales by Region (2019-2025) & (K Units)
Table 43. Global Natural Killer Cell Therapeutics Production (K Units) by Region (2019-2025)
Table 44. Global Natural Killer Cell Therapeutics Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Natural Killer Cell Therapeutics Revenue Market Share by Region (2019-2025)
Table 46. Global Natural Killer Cell Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Natural Killer Cell Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Natural Killer Cell Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Natural Killer Cell Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Natural Killer Cell Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Merck KGaA Natural Killer Cell Therapeutics Basic Information
Table 52. Merck KGaA Natural Killer Cell Therapeutics Product Overview
Table 53. Merck KGaA Natural Killer Cell Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Merck KGaA Business Overview
Table 55. Merck KGaA Natural Killer Cell Therapeutics SWOT Analysis
Table 56. Merck KGaA Recent Developments
Table 57. Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Basic Information
Table 58. Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Product Overview
Table 59. Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Bristol-Myers Squibb Company Business Overview
Table 61. Bristol-Myers Squibb Company Natural Killer Cell Therapeutics SWOT Analysis
Table 62. Bristol-Myers Squibb Company Recent Developments
Table 63. Glycostem Natural Killer Cell Therapeutics Basic Information
Table 64. Glycostem Natural Killer Cell Therapeutics Product Overview
Table 65. Glycostem Natural Killer Cell Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Glycostem Natural Killer Cell Therapeutics SWOT Analysis
Table 67. Glycostem Business Overview
Table 68. Glycostem Recent Developments
Table 69. Sanofi Natural Killer Cell Therapeutics Basic Information
Table 70. Sanofi Natural Killer Cell Therapeutics Product Overview
Table 71. Sanofi Natural Killer Cell Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Sanofi Business Overview
Table 73. Sanofi Recent Developments
Table 74. Cytovia Therapeutics Natural Killer Cell Therapeutics Basic Information
Table 75. Cytovia Therapeutics Natural Killer Cell Therapeutics Product Overview
Table 76. Cytovia Therapeutics Natural Killer Cell Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Cytovia Therapeutics Business Overview
Table 78. Cytovia Therapeutics Recent Developments
Table 79. ImmunityBio Natural Killer Cell Therapeutics Basic Information
Table 80. ImmunityBio Natural Killer Cell Therapeutics Product Overview
Table 81. ImmunityBio Natural Killer Cell Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. ImmunityBio Business Overview
Table 83. ImmunityBio Recent Developments
Table 84. Inc. Natural Killer Cell Therapeutics Basic Information
Table 85. Inc. Natural Killer Cell Therapeutics Product Overview
Table 86. Inc. Natural Killer Cell Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Inc. Business Overview
Table 88. Inc. Recent Developments
Table 89. Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Basic Information
Table 90. Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Product Overview
Table 91. Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Biohaven Pharmaceuticals Business Overview
Table 93. Biohaven Pharmaceuticals Recent Developments
Table 94. Fate Therapeutics Natural Killer Cell Therapeutics Basic Information
Table 95. Fate Therapeutics Natural Killer Cell Therapeutics Product Overview
Table 96. Fate Therapeutics Natural Killer Cell Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Fate Therapeutics Business Overview
Table 98. Fate Therapeutics Recent Developments
Table 99. EMERcell Natural Killer Cell Therapeutics Basic Information
Table 100. EMERcell Natural Killer Cell Therapeutics Product Overview
Table 101. EMERcell Natural Killer Cell Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. EMERcell Business Overview
Table 103. EMERcell Recent Developments
Table 104. Phio Pharmaceuticals Natural Killer Cell Therapeutics Basic Information
Table 105. Phio Pharmaceuticals Natural Killer Cell Therapeutics Product Overview
Table 106. Phio Pharmaceuticals Natural Killer Cell Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Phio Pharmaceuticals Business Overview
Table 108. Phio Pharmaceuticals Recent Developments
Table 109. Global Natural Killer Cell Therapeutics Sales Forecast by Region (2025-2032) & (K Units)
Table 110. Global Natural Killer Cell Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 111. North America Natural Killer Cell Therapeutics Sales Forecast by Country (2025-2032) & (K Units)
Table 112. North America Natural Killer Cell Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 113. Europe Natural Killer Cell Therapeutics Sales Forecast by Country (2025-2032) & (K Units)
Table 114. Europe Natural Killer Cell Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 115. Asia Pacific Natural Killer Cell Therapeutics Sales Forecast by Region (2025-2032) & (K Units)
Table 116. Asia Pacific Natural Killer Cell Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 117. South America Natural Killer Cell Therapeutics Sales Forecast by Country (2025-2032) & (K Units)
Table 118. South America Natural Killer Cell Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 119. Middle East and Africa Natural Killer Cell Therapeutics Consumption Forecast by Country (2025-2032) & (Units)
Table 120. Middle East and Africa Natural Killer Cell Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 121. Global Natural Killer Cell Therapeutics Sales Forecast by Type (2025-2032) & (K Units)
Table 122. Global Natural Killer Cell Therapeutics Market Size Forecast by Type (2025-2032) & (M USD)
Table 123. Global Natural Killer Cell Therapeutics Price Forecast by Type (2025-2032) & (USD/Unit)
Table 124. Global Natural Killer Cell Therapeutics Sales (K Units) Forecast by Application (2025-2032)
Table 125. Global Natural Killer Cell Therapeutics Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Natural Killer Cell Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Natural Killer Cell Therapeutics Market Size (M USD), 2019-2032
Figure 5. Global Natural Killer Cell Therapeutics Market Size (M USD) (2019-2032)
Figure 6. Global Natural Killer Cell Therapeutics Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Natural Killer Cell Therapeutics Market Size by Country (M USD)
Figure 11. Natural Killer Cell Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Natural Killer Cell Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Natural Killer Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Natural Killer Cell Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Natural Killer Cell Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Natural Killer Cell Therapeutics Market Share by Type
Figure 18. Sales Market Share of Natural Killer Cell Therapeutics by Type (2019-2025)
Figure 19. Sales Market Share of Natural Killer Cell Therapeutics by Type in 2023
Figure 20. Market Size Share of Natural Killer Cell Therapeutics by Type (2019-2025)
Figure 21. Market Size Market Share of Natural Killer Cell Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Natural Killer Cell Therapeutics Market Share by Application
Figure 24. Global Natural Killer Cell Therapeutics Sales Market Share by Application (2019-2025)
Figure 25. Global Natural Killer Cell Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Natural Killer Cell Therapeutics Market Share by Application (2019-2025)
Figure 27. Global Natural Killer Cell Therapeutics Market Share by Application in 2023
Figure 28. Global Natural Killer Cell Therapeutics Sales Growth Rate by Application (2019-2025)
Figure 29. Global Natural Killer Cell Therapeutics Sales Market Share by Region (2019-2025)
Figure 30. North America Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Natural Killer Cell Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Natural Killer Cell Therapeutics Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Natural Killer Cell Therapeutics Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Natural Killer Cell Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Natural Killer Cell Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Natural Killer Cell Therapeutics Sales Market Share by Region in 2023
Figure 44. China Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Natural Killer Cell Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Natural Killer Cell Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Natural Killer Cell Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Natural Killer Cell Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Natural Killer Cell Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Natural Killer Cell Therapeutics Production Market Share by Region (2019-2025)
Figure 62. North America Natural Killer Cell Therapeutics Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Natural Killer Cell Therapeutics Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Natural Killer Cell Therapeutics Production (K Units) Growth Rate (2019-2025)
Figure 65. China Natural Killer Cell Therapeutics Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Natural Killer Cell Therapeutics Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Natural Killer Cell Therapeutics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Natural Killer Cell Therapeutics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Natural Killer Cell Therapeutics Market Share Forecast by Type (2025-2032)
Figure 70. Global Natural Killer Cell Therapeutics Sales Forecast by Application (2025-2032)
Figure 71. Global Natural Killer Cell Therapeutics Market Share Forecast by Application (2025-2032)
